Argenx buyout of peptide engine and Big Pharma favorite UNP could top $1B
Argenx is putting up to $1.15 billion on the line to buy out peptide partner Unnatural Products, a company that also counts Novartis and Merck as
From the source
Read at biospace.comArgenx buyout of peptide engine and Big Pharma favorite UNP could top $1B
Argenx is putting up to $1.15 billion on the line to buy out peptide partner Unnatural Products, a company that also counts Novartis and Merck as collaborators.
